Skip to main content
. 2018 Oct 1;4(4):126–136. doi: 10.2478/jccm-2018-0018

Table 3.

Checklist results for medical case B

Element Number of teams “Yes”/initial Number of teams “Yes”/final Number of teams “No”/initial Number of teams “No”/final Likelihood Ratio*
Consciousness
 10
 10
 0
 0
ABC evaluation < 2 minutes
 10
 10
 0
 0
Oxygen administration **
 10
 10
 0
 0
Sitting position **
 9
 10
 1
 0
Monitoring Electrocardiogram
 10
 10
 0
 0
Blood pressure
 10
 10
 0
 0
Oxygen saturation
 10
 10
 0
 0
Temperature
 6
 1
 4
 9
 0.015
Focused clinical Cardiac auscultation
 4
 8
 6
 2
 0.063
examination Pulmonary auscultation
 9
 8
 1
 2
 0.528
Jugular veins
 1
 3
 9
 7
 0.255
Signs of PVT/edema
 9
 10
 1
 0
Focused history Anamnesis
 10
 10
 0
 0
Past medical history
 10
 10
 0
 0
Treatment
 10
 10
 0
 0
12-lead electrocardiogram**
 10
 10
 0
 0
Intravenous line **
 10
 10
 0
 0
Arterial blood gases (ABG)
 10
 10
 0
 0
Lab tests CBC, electrolytes, Renal &hepatic tests
 10
 10
 0
 0
CRP
 0
 0
 10
 10
NT-proBNP
 8
 9
 2
 1
 0.528
Troponin
 9
 8
 1
 2
 0.528
D-dimers
 9
 10
 1
 0
Chest radiography
 6
 4
 4
 6
 0.369
Fluids bolus
 2
 9
 8
 1
 0.001
Give β2mimetics
 8
 2
 2
 8
 0.005
Request angioCT scan **
 10
 8
 0
 2
Angio-CT scan performed
 6
 2
 4
 6
 0.132
Request cardiac ultrasound **
 2
 7
 8
 3
 0.021
Request venous Doppler ultrasound
 2
 0
 8
 10
Decide to thrombolysis **
 9
 10
 1
 0
Verify contraindications to thrombolysis
 2
 7
 8
 3
 0.021
Start thrombolysis **
 9
 10
 1
 0
Ask for cardiologic advise **
 10
 10
 0
 0
Differential Exacerbation of COPD+ pneumonia
 6
 9
 4
 1
 0.112
diagnosis Acute pulmonary edema
 4
 5
 6
 5
 0.653
Acute coronary syndrome
 5
 10
 5
 0
Pulmonary embolism
 10
 10
 0
 0
Spontaneous pneumothorax
 5
 8
 5
 2
 0.155
Correct diagnosis
 10
 10
 0
 0
Recognize β2mimetics overdose
 2
 8
 8
 2
 0.005
*

Chi-Square Test; ** Time to achievement recorded; ABC- airway, breathing, circulation, PVT-profound venous thrombosis, CBC- complete blood count, NT-proBNP- N-terminal pro b-type natriuretic peptide, COPD-chronic obstructive pulmonary disease